A new look at osteoporosis outcomes: The influence of treatment, compliance, persistence, and adherence

被引：21
作者：
Badamgarav, Enkhe [1 ]
Fitzpatrick, Lorraine A. [1 ]
机构：
[1] Amgen Inc, Thousand Oaks, CA 91320 USA
来源：
MAYO CLINIC PROCEEDINGS | 2006年 / 81卷 / 08期
关键词：
D O I：
10.4065/81.8.1009
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1009 / 1012
页数：4
相关论文
共 27 条
  • [11] Effects of risedronate treatment on vertebral and nonvertebral fractures in women with postmenopausal osteoporosis - A randomized controlled trial
    Harris, ST
    Watts, NB
    Genant, HK
    McKeever, CD
    Hangartner, T
    Keller, M
    Chesnut, CH
    Brown, J
    Eriksen, EF
    Hoseyni, MS
    Axelrod, DW
    Miller, PD
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1999, 282 (14): : 1344 - 1352
  • [12] Assessment of compliance with osteoporosis treatment and its consequences in a managed care population
    Huybrechts, KF
    Ishak, KJ
    Caro, JJ
    [J]. BONE, 2006, 38 (06) : 922 - 928
  • [13] Mortality after osteoporotic fractures
    Johnell, O
    Kanis, JA
    Odén, A
    Sernbo, I
    Redlund-Johnell, I
    Petterson, C
    De Laet, C
    Jönsson, B
    [J]. OSTEOPOROSIS INTERNATIONAL, 2004, 15 (01) : 38 - 42
  • [14] Persistence with weekly alendronate therapy among postmenopausal women
    Lo, J. C.
    Pressman, A. R.
    Omar, M. A.
    Ettinger, B.
    [J]. OSTEOPOROSIS INTERNATIONAL, 2006, 17 (06) : 922 - 928
  • [15] Compliance with drug therapies for the treatment and prevention of osteoporosis
    McCombs, JS
    Thiebaud, P
    McLaughlin-Miley, C
    Shi, JH
    [J]. MATURITAS, 2004, 48 (03) : 271 - 287
  • [16] Determinants of persistence with bisphosphonates: A study in women with postmenopausal osteoporosis
    Penning-van Beest, FJA
    Goettsch, WG
    Erkens, JA
    Herings, RMC
    [J]. CLINICAL THERAPEUTICS, 2006, 28 (02) : 236 - 242
  • [17] Medical expenditures for the treatment of osteoporotic fractures in the United States in 1995: Report from the national osteoporosis foundation
    Ray, NF
    Chan, JK
    Thamer, M
    Melton, LJ
    [J]. JOURNAL OF BONE AND MINERAL RESEARCH, 1997, 12 (01) : 24 - 35
  • [18] Insufficiently dosed intravenous ibandronate injections are associated with suboptimal antifracture efficacy in postmenopausal osteoporosis
    Recker, R
    Stakkestad, JA
    Chesnut, CH
    Christiansen, C
    Skag, A
    Hoiseth, A
    Ettinger, M
    Mahoney, P
    Schimmer, RC
    Delmas, DP
    [J]. BONE, 2004, 34 (05) : 890 - 899
  • [19] Effect of dosing frequency on bisphosphonate medication adherence in a large longitudinal cohort of women
    Recker, RR
    Gallagher, R
    MacCosbe, PE
    [J]. MAYO CLINIC PROCEEDINGS, 2005, 80 (07) : 856 - 861
  • [20] Adherence, patient preference and dosing frequency: Understanding the relationship
    Reginster, JY
    Rabenda, V
    Neuprez, A
    [J]. BONE, 2006, 38 (04) : S2 - S6
123